Ekso Bionics Holdings, Inc. (EKSO)

Ekso Bionics Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	22	36	16	34	51	29
Market Cap Growth	10.61%	127.55%	-53.40%	-34.17%	73.95%	-62.27%
Enterprise Value	20	34	3	-5	42	22
PE Ratio	-	-2.34	-1.04	-3.44	-3.22	-2.42
PS Ratio	1.23	1.95	1.21	2.98	5.74	2.11
PB Ratio	1.57	2.82	0.62	0.90	11.50	4.31
P/FCF Ratio	-2.13	-2.91	-1.05	-2.99	-5.82	-1.85
P/OCF Ratio	-2.15	-2.95	-1.06	-3.01	-5.82	-1.86
EV/Sales Ratio	1.12	1.87	0.20	-0.41	4.73	1.60
EV/EBITDA Ratio	-1.82	-2.59	-0.19	0.54	-2.79	-2.02
EV/EBIT Ratio	-1.60	-2.29	-0.18	0.48	-2.68	-1.90
EV/FCF Ratio	-1.96	-2.79	-0.18	0.41	-4.79	-1.41
Debt / Equity Ratio	0.49	0.57	0.29	0.06	0.87	0.57
Debt / EBITDA Ratio	-0.56	-0.54	-0.53	-0.26	-0.26	-0.35
Debt / FCF Ratio	-0.60	-0.59	-0.50	-0.20	-0.44	-0.24
Quick Ratio	1.99	1.76	2.73	6.57	3.23	2.05
Current Ratio	2.81	2.49	3.37	6.97	3.70	2.40
Asset Turnover	0.58	0.56	0.31	0.22	0.43	0.63
Interest Coverage	-56.41	-49.32	-95.67	-85.41	-112.85	-30.59
Return on Equity (ROE)	-95.40%	-90.80%	-50.60%	-24.80%	-351.00%	-209.60%
Return on Assets (ROA)	-46.30%	-46.30%	-36.60%	-18.70%	-75.90%	-54.70%
Return on Capital (ROIC)	-66.63%	-76.42%	-47.22%	-35.06%	-160.33%	-155.96%
Earnings Yield	-64.48%	-42.71%	-96.42%	-29.10%	-31.04%	-41.40%
FCF Yield	-51.76%	-34.31%	-95.04%	-33.42%	-17.17%	-54.02%
Buyback Yield / Dilution	-31.01%	-6.98%	-5.65%	-71.26%	-49.44%	-17.44%
Total Shareholder Return	-31.01%	-6.98%	-5.65%	-71.26%	-49.44%	-17.44%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).